Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

This letter comments on the article which reported that tenofovir alafenamide may increase blood lipid levels compared with entecavir in patients with chronic hepatitis B published on 2023 August 27. We review the related research content, topic selection, methodology, conclusions, strengths and wea...

Full description

Saved in:
Bibliographic Details
Published in:World journal of hepatology 2024-01, Vol.16 (1), p.109-111
Main Authors: Sun, Yu-Tong, Chen, Qian-Qian
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c290t-8e31d0798cb3c5928afd4e6d2a348fd9fc86ae15a586490f192a5a7b02a8fb2f3
container_end_page 111
container_issue 1
container_start_page 109
container_title World journal of hepatology
container_volume 16
creator Sun, Yu-Tong
Chen, Qian-Qian
description This letter comments on the article which reported that tenofovir alafenamide may increase blood lipid levels compared with entecavir in patients with chronic hepatitis B published on 2023 August 27. We review the related research content, topic selection, methodology, conclusions, strengths and weaknesses of this article. And evaluate it in relation to other published relevant articles.
doi_str_mv 10.4254/wjh.v16.i1.109
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2922451697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2922451697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-8e31d0798cb3c5928afd4e6d2a348fd9fc86ae15a586490f192a5a7b02a8fb2f3</originalsourceid><addsrcrecordid>eNpNkElPwzAQhS0EolXplSPykUtCvCSxj1CxSZWQEJytiTNWXWUpcdKKf0-iFsRcZnnfvMMj5JolseSpvDtsN_GeZbFnMUv0GZkzLVWUMsXP_80zsgxhm4wlZaaVuiQzoQQTXOZz4t9x7_FA24ZC13tbIW0dRefQ9mEae2xa1-59R6EChw3UvkQKTUmx6dHCpPiG2k3XNt7SDe6g970P9IGO0hDotI9ouCIXDqqAy1NfkM-nx4_VS7R-e35d3a8jy3XSRwoFK5NcK1sIm2quwJUSs5KDkMqV2lmVAbIUUpVJnTimOaSQFwkH5QruxILcHn13Xfs1YOhN7YPFqoIG2yEYrjmXKct0PqLxEbVdG0KHzuw6X0P3bVhipoTNmLAZEzaejSc9PtycvIeixvIP_81T_AABaXlS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2922451697</pqid></control><display><type>article</type><title>Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients</title><source>PubMed Central</source><creator>Sun, Yu-Tong ; Chen, Qian-Qian</creator><creatorcontrib>Sun, Yu-Tong ; Chen, Qian-Qian</creatorcontrib><description>This letter comments on the article which reported that tenofovir alafenamide may increase blood lipid levels compared with entecavir in patients with chronic hepatitis B published on 2023 August 27. We review the related research content, topic selection, methodology, conclusions, strengths and weaknesses of this article. And evaluate it in relation to other published relevant articles.</description><identifier>ISSN: 1948-5182</identifier><identifier>EISSN: 1948-5182</identifier><identifier>DOI: 10.4254/wjh.v16.i1.109</identifier><identifier>PMID: 38313247</identifier><language>eng</language><publisher>United States</publisher><ispartof>World journal of hepatology, 2024-01, Vol.16 (1), p.109-111</ispartof><rights>The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c290t-8e31d0798cb3c5928afd4e6d2a348fd9fc86ae15a586490f192a5a7b02a8fb2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38313247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Yu-Tong</creatorcontrib><creatorcontrib>Chen, Qian-Qian</creatorcontrib><title>Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients</title><title>World journal of hepatology</title><addtitle>World J Hepatol</addtitle><description>This letter comments on the article which reported that tenofovir alafenamide may increase blood lipid levels compared with entecavir in patients with chronic hepatitis B published on 2023 August 27. We review the related research content, topic selection, methodology, conclusions, strengths and weaknesses of this article. And evaluate it in relation to other published relevant articles.</description><issn>1948-5182</issn><issn>1948-5182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkElPwzAQhS0EolXplSPykUtCvCSxj1CxSZWQEJytiTNWXWUpcdKKf0-iFsRcZnnfvMMj5JolseSpvDtsN_GeZbFnMUv0GZkzLVWUMsXP_80zsgxhm4wlZaaVuiQzoQQTXOZz4t9x7_FA24ZC13tbIW0dRefQ9mEae2xa1-59R6EChw3UvkQKTUmx6dHCpPiG2k3XNt7SDe6g970P9IGO0hDotI9ouCIXDqqAy1NfkM-nx4_VS7R-e35d3a8jy3XSRwoFK5NcK1sIm2quwJUSs5KDkMqV2lmVAbIUUpVJnTimOaSQFwkH5QruxILcHn13Xfs1YOhN7YPFqoIG2yEYrjmXKct0PqLxEbVdG0KHzuw6X0P3bVhipoTNmLAZEzaejSc9PtycvIeixvIP_81T_AABaXlS</recordid><startdate>20240127</startdate><enddate>20240127</enddate><creator>Sun, Yu-Tong</creator><creator>Chen, Qian-Qian</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240127</creationdate><title>Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients</title><author>Sun, Yu-Tong ; Chen, Qian-Qian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-8e31d0798cb3c5928afd4e6d2a348fd9fc86ae15a586490f192a5a7b02a8fb2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Sun, Yu-Tong</creatorcontrib><creatorcontrib>Chen, Qian-Qian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Yu-Tong</au><au>Chen, Qian-Qian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients</atitle><jtitle>World journal of hepatology</jtitle><addtitle>World J Hepatol</addtitle><date>2024-01-27</date><risdate>2024</risdate><volume>16</volume><issue>1</issue><spage>109</spage><epage>111</epage><pages>109-111</pages><issn>1948-5182</issn><eissn>1948-5182</eissn><abstract>This letter comments on the article which reported that tenofovir alafenamide may increase blood lipid levels compared with entecavir in patients with chronic hepatitis B published on 2023 August 27. We review the related research content, topic selection, methodology, conclusions, strengths and weaknesses of this article. And evaluate it in relation to other published relevant articles.</abstract><cop>United States</cop><pmid>38313247</pmid><doi>10.4254/wjh.v16.i1.109</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-5182
ispartof World journal of hepatology, 2024-01, Vol.16 (1), p.109-111
issn 1948-5182
1948-5182
language eng
recordid cdi_proquest_miscellaneous_2922451697
source PubMed Central
title Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A45%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20on%20article%20of%20effects%20of%20tenofovir%20alafenamide%20and%20entecavir%20in%20chronic%20hepatitis%20B%20virus%20patients&rft.jtitle=World%20journal%20of%20hepatology&rft.au=Sun,%20Yu-Tong&rft.date=2024-01-27&rft.volume=16&rft.issue=1&rft.spage=109&rft.epage=111&rft.pages=109-111&rft.issn=1948-5182&rft.eissn=1948-5182&rft_id=info:doi/10.4254/wjh.v16.i1.109&rft_dat=%3Cproquest_cross%3E2922451697%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c290t-8e31d0798cb3c5928afd4e6d2a348fd9fc86ae15a586490f192a5a7b02a8fb2f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2922451697&rft_id=info:pmid/38313247&rfr_iscdi=true